| Pre-therapeutic dosimetry of normal organs and tissues of 177Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration … L Kabasakal, M AbuQbeitah, A Aygün, N Yeyin, M Ocak, E Demirci, ... European journal of nuclear medicine and molecular imaging 42, 1976-1983, 2015 | 221 | 2015 |
| Lu-177-PSMA-617 prostate specific membrane antigen (PSMA) inhibitor therapy in patients with castration resistant prostate cancer: Stability, bio-distribution and dosimetry L Kabasakal, T Toklu, N Yeyin, E Demirci, M Abuqbeitah, M Ocak, ... | 89 | 2017 |
| Evaluation of radiation safety in 177Lu-PSMA therapy and development of outpatient treatment protocol M Demir, M Abuqbeitah, L Uslu-Beşli, Ö Yıldırım, N Yeyin, İ Çavdar, ... Journal of Radiological Protection 36 (2), 269, 2016 | 62 | 2016 |
| Blood clearance and occupational exposure for 177Lu-DOTATATE compared to 177Lu-PSMA radionuclide therapy M Abuqbeitah, M Demir, L Uslu-Beşli, N Yeyin, K Sönmezoğlu Radiation and Environmental Biophysics 57, 55-61, 2018 | 25 | 2018 |
| The evaluation of urine activity and external dose rate from patients receiving radioiodine therapy for thyroid cancer M Demir, Y Parlak, I Çavdar, N Yeyin, H Tanyildizi, G Gümüşer, E Sayit, ... Radiation protection dosimetry 156 (1), 25-29, 2013 | 24 | 2013 |
| Radyasyonun biyolojik etkileri N Yeyin Nucl Med Semin 1 (3), 139-143, 2015 | 20 | 2015 |
| Small molecule, multimodal,[18F]-PET and fluorescence imaging agent targeting prostate-specific membrane antigen: first-in-human study O Aras, C Demirdag, H Kommidi, H Guo, I Pavlova, A Aygun, E Karayel, ... Clinical genitourinary cancer 19 (5), 405-416, 2021 | 18 | 2021 |
| Evaluation of PET scanner performance in PET/MR and PET/CT systems: NEMA tests M Demir, T Toklu, M Abuqbeitah, H Çetin, N Yeyin, K Sönmezoğlu | 17 | 2018 |
| Determining and managing fetal radiation dose from diagnostic radiology procedures in Turkey M Ozbayrak, I Cavdar, M Seven, L Uslu, N Yeyin, H Tanyildizi, ... Korean journal of radiology 16 (6), 1276-1282, 2015 | 17 | 2015 |
| Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with … S Sager, E Akgün, L Uslu-Besli, S Asa, B Akovali, O Sahin, N Yeyin, ... Nuclear Medicine Communications 40 (5), 461-468, 2019 | 16 | 2019 |
| ESTIMATION OF THE ORGAN ABSORBED DOSES AND EFFECTIVE DOSE FROM 68Ga-PSMA-11 PET SCAN E Demirci, T Toklu, N Yeyin, M Ocak, N Alan-Selcuk, A Araman, ... Radiation protection dosimetry 182 (4), 518-524, 2018 | 15 | 2018 |
| Effects of hemodialysis on iodine-131 biokinetics in thyroid carcinoma patients with end-stage chronic renal failure N Yeyin, I Cavdar, L Uslu, M Abuqbeitah, M Demir Nuclear Medicine Communications 37 (3), 283-287, 2016 | 15 | 2016 |
| Radyasyon güvenliği kılavuzu: genel tanımlar ve nükleer tıp uygulamalarında radyasyondan korunma kuralları Y Parlak, B Uysal, FS Kıraç, B Kovan, M Demir, A Ayan, L Poyraz, ... Nuclear Medicine Seminars, 2020 | 11 | 2020 |
| Red bone marrow dose estimation using several internal dosimetry models for prospective dosimetry-oriented radioiodine therapy M Abuqbeitah, M Demir, İ Çavdar, H Tanyildizi, N Yeyin, L Uslu-Beşli, ... Radiation and Environmental Biophysics 57, 395-404, 2018 | 11 | 2018 |
| Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer M Abuqbeitah, M Demir, L Kabasakal, İ Çavdar, L Uslu-Besli, N Yeyin, ... Nuclear Medicine Communications 39 (11), 969-975, 2018 | 9 | 2018 |
| Dose calibrator measurements in the case of voltage fluctuations O Günay, İN Altıntaş, M Demir, N Yeyin International Journal of Computational and Experimental Science and …, 2023 | 7 | 2023 |
| The impact of different computational assumptions in 131I dosimetry for hyperthyroidism therapy M Abuqbeitah, S Sağer, M Demir, N Yeyin, B Akovalı, K Sönmezoğlu Medical Physics 47 (11), 5810-5816, 2020 | 5 | 2020 |
| Thyroid uptake test with portable device (COTI) after 131I tracer administration: proof of concept M Abuqbeitah, M Demir, N Yeyin, S Sager, D Gray Radiation and environmental biophysics 59, 553-558, 2020 | 5 | 2020 |
| The Evaluation of Dose Rate Measurements and Patients Discharge In Radionuclide Therapy N Yeyin, M Abuqbeıtah, İ Çavdar, K Sönmezoğlu, M Demir Journal of Istanbul Faculty of Medicine 80 (1), 1-6, 2017 | 5 | 2017 |
| Radiation dose of caregivers could be reduced in thyroid carcinoma patients requiring high dose of radioactive iodine: A case report L Uslu-Besli, M Demir, N Yeyin, İ Çavdar Iranian Journal of Nuclear Medicine 24 (2), 144, 2016 | 5 | 2016 |
